UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

Journal of public health, 2022-02, Vol.30 (2), p.409-415

2022

Link zum Volltext

Verfügbarkeit prüfen

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Journal of public health, 2021-02, Vol.29 (1), p.9-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.779-792

2021

Link zum Volltext

Verfügbarkeit prüfen

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Forensic toxicology, 2020, Vol.38 (1), p.59-69

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil

Metabolites, 2024-06, Vol.14 (6), p.342

2024

Link zum Volltext

Verfügbarkeit prüfen

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2996-3003

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Cancer cell international, 2018-05, Vol.18 (1), p.69-69, Article 69

2018

Link zum Volltext

Verfügbarkeit prüfen

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Metabolites, 2020-12, Vol.11 (1), p.3

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Journal of experimental & clinical cancer research, 2014-02, Vol.33 (1), p.15-15, Article 15

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting adipose tissue

Diabetology and metabolic syndrome, 2012-10, Vol.4 (1), p.43-43, Article 43

2012

Link zum Volltext

Verfügbarkeit prüfen

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.238

2010

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

The Journal of biological chemistry, 2008-01, Vol.283 (2), p.739-750

2008

Link zum Volltext

Verfügbarkeit prüfen

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6144-6151

2009

Link zum Volltext

Verfügbarkeit prüfen

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

International journal of pharmaceutics, 2010-04, Vol.389 (1), p.10-17

2010

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy of Cushing's syndrome

Orphanet journal of rare diseases, 2014-08, Vol.9 (1), p.122-122, Article 122

2014

Link zum Volltext

Verfügbarkeit prüfen

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

Blood, 2008-04, Vol.111 (7), p.3714-3722

2008

Link zum Volltext

Verfügbarkeit prüfen

Acquired cisplatin resistance in the head–neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1

International journal of cancer, 2008-11, Vol.123 (9), p.2013-2019

2008

Link zum Volltext

Verfügbarkeit prüfen

Resistenzmechanismen von Tumoren gegen Platinkomplexe: Neue Drug Targets und diagnostische Marker

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008, 2021, p.249-262

2021

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective

GaBI Journal, 2014-06, Vol.3 (2), p.79-87

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer CellsS

The Journal of biological chemistry, 2007-10, Vol.283 (2), p.739-750

2007

Link zum Volltext

Verfügbarkeit prüfen

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma

Blood, 2005-11, Vol.106 (11), p.3385-3385

2005

Link zum Volltext

Verfügbarkeit prüfen

Jahrbuch der Heinrich-Heine-Universitat Dusseldorf 2007/2008

Dusseldorf, Rektor der Heinrich-Heine-Universitat

2008

Link zum Volltext

Verfügbarkeit prüfen

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008

Düsseldorf, Rektor der Heinrich-Heine-Universität

2008

Link zum Volltext

Verfügbarkeit prüfen

Functional Screening of G Protein–Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader

SLAS discovery, 2002-06, Vol.7 (3), p.233-246

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

Clinical cancer research, 2018-06, Vol.24 (12), p.2951-2962

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Humans
(11)
Oncology
(8)
Cell Line, Tumor
(7)
Antineoplastic Agents
(5)
Antineoplastic Agents - Pharmacology
(5)
Biological And Medical Sciences
(5)
Female
(5)
Medical Sciences
(5)
Medicine
(5)
Medicine & Public Health
(5)
Pharmacology. Drug Treatments
(5)
Cisplatin - Pharmacology
(4)
Drug Resistance, Neoplasm
(4)
Physiological Aspects
(4)
Tumors
(4)
Biochemistry & Molecular Biology
(3)
Cisplatin
(3)
Diabetes
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Targeting adipose tissue

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

Systemic therapy of Cushing's syndrome

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

Acquired cisplatin resistance in the head–neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1

Resistenzmechanismen von Tumoren gegen Platinkomplexe: Neue Drug Targets und diagnostische Marker

Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer CellsS

The Y-box Binding Protein YB-1 Is Associated with Progressive Disease and Mediates Survival and Drug Resistance in Multiple Myeloma

Jahrbuch der Heinrich-Heine-Universitat Dusseldorf 2007/2008

Jahrbuch der Heinrich-Heine-Universität Düsseldorf 2007/2008

Functional Screening of G Protein–Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader

Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

Aktive Filter

Suchergebnisse filtern